TS Financial Group (TSFG)’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-50
Closed -$4K 879
2023
Q4
$4K Buy
+50
New +$3.92K ﹤0.01% 652

Other funds holding PPH

TS Financial Group (TSFG)'s PPH Position: Q1 2024 in Review

TS Financial Group (TSFG) sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2024, closing a stake of 50 shares — an estimated $4K sold.

TS Financial Group (TSFG) first reported a position in PPH in Q4 2023 and held it in 1 quarter. The position peaked at $4K in Q4 2023. 138 funds tracked by Wall St. Rank hold PPH as of Q1 2024.

  • TS Financial Group (TSFG) reported no remaining VanEck Pharmaceutical ETF position as of Q1 2024 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 50 VanEck Pharmaceutical ETF shares in Q1 2024, an estimated $4K.
  • TS Financial Group (TSFG) first reported a position in VanEck Pharmaceutical ETF in Q4 2023 and held it in 1 quarter.
  • TS Financial Group (TSFG)'s VanEck Pharmaceutical ETF position peaked at $4K in Q4 2023.
  • 138 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2024.

Based on TS Financial Group (TSFG)'s 13F filing for Q1 2024, filed 16 Apr 2024.